FDA Greenlights First Motion Sickness Drug in More Than 40 Years

(MedPage Today) -- The FDA approved tradipitant (Nereus), an oral neurokinin-1 (NK-1) receptor antagonist, to prevent vomiting induced by motion in adults, Vanda Pharmaceuticals announced Tuesday.
The approval marks the first new drug treatment...